MedTrace Logo

Validation of the SentiCor-300 Continuous Noninvasive Blood Pressure

NCT05625256 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-08-07

No results posted yet for this study

Summary

To compare continuous arterial pressures obtained from the SentiCor-300 with direct intra-arterial blood pressure measurements at various stages of anesthesia (such as induction, laryngoscopy, maintenance, emergence, and recovery) and after emergence in supine position.

Conditions

  • Blood Pressure

Interventions

DEVICE

SentiCor-300

Continuous blood pressure measurement with the SentiCor-300.

Sponsors & Collaborators

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Alparslan Turan, MD · The Cleveland Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-30
Primary Completion
2023-11-30
Completion
2024-11-30
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05625256 on ClinicalTrials.gov